Evidence map›Paper›PMID 31438915›Full record

ArticleBMC endocrine disorders2019

Glycated hemoglobin versus oral glucose tolerance test in the identification of subjects with prediabetes in Qatari population.

Saadallah Iskandar, Ayman Migahid, Dalia Kamal, Osama Megahed, Ralph A DeFronzo, Mahmoud Zirie, Amin Jayyousi, Mahmood Al Jaidah, Muhammad Abdul-Ghani

Open access · goldAbstract readComparative Study
In one paragraph

Article in BMC endocrine disorders, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Prevalence of Prediabetes and Undiagnosed Diabetes Among Kuwaiti Adults: A Cross-Sectional Study.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021
    Article
  4. Article
  5. The Oral Glucose Tolerance Test: 100 Years Later.Diabetes, metabolic syndrome and obesity : targets and therapy · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Saadallah IskandarQatar Petroleum, Doha, Qatar.
Ayman MigahidAcademic Health System, Hamad General Hospital, PO Box 3050, Doha, Qatar.
Dalia KamalAcademic Health System, Hamad General Hospital, PO Box 3050, Doha, Qatar.
Osama MegahedAcademic Health System, Hamad General Hospital, PO Box 3050, Doha, Qatar.
Ralph A DeFronzoDiabetes Division, University of Texas Health Science Center, San Antonio, TX, USA.
Mahmoud ZirieAcademic Health System, Hamad General Hospital, PO Box 3050, Doha, Qatar.
Amin JayyousiAcademic Health System, Hamad General Hospital, PO Box 3050, Doha, Qatar.
Mahmood Al JaidahQatar Petroleum, Doha, Qatar.
Muhammad Abdul-GhaniAcademic Health System, Hamad General Hospital, PO Box 3050, Doha, Qatar. abdulghani@uthscsa.edu.ORCID http://orcid.org/0000-0003-4556-1787
Hamad General Hospital · QAQatar Petroleum (Qatar) · QAThe University of Texas Health Science Center at San Antonio · US

Funding

Qatar Foundation NPRP 4-248-3-076
6 · The paper itself

Abstract

backgroundSubjects with prediabetes are at increased risk of future T2DM and cardiovascular disease (CVD) compared to NGT individuals. The OGTT (FPG = 100-125 and 2 h-PG = 140-199 mg/dl) and HbA1c 5.7-6.4% have been used to diagnose subjects with prediabetes. In the present study, we compared the ability of the OGTT and HbA1c to identify Qatari subjects with prediabetes.

methodsFour hundred forty six subjects without a history of T2DM received 75-g OGTT and measurement of HbA1c. The incidence of prediabetes in this cohort according to OGTT criteria was compared to that of HbA1c criteria.

resultsThe agreement between the OGTT and HbA1c in identifying subjects with prediabetes in Qatari subjects was poor, though significant (k = 015, p < 0.0001). Only 56% of participants had prediabetes or NGT according to OGTT and HbA1c. The disagreement between OGTT and HbA1c in diagnosing prediabetes was primarily due to low sensitivity of HbA1c. Moreover, subjects with prediabetes diagnosed with the OGTT have more severe metabolic profile than prediabetic subjects diagnosed with HbA1c. Lastly, more subjects with the metabolic syndrome were identified with OGTT (60%) criteria than with the HbA1c (49%), p < 0.0001.

conclusionThese results demonstrate subjects with prediabetes diagnosed with OGTT have more severe metabolic risk than those diagnosed with HbA1c, and more likely to have greater risk of progression to T2DM.

Indexed as

AdultBiomarkersBlood GlucoseCase-Control StudiesDiabetes Mellitus, Type 2FemaleFollow-Up StudiesGlucose Tolerance TestGlycated HemoglobinHumansMaleMiddle AgedPrediabetic StatePrognosisRetrospective StudiesBiomarkersBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanHbA1cOGTTPrediabetesType 2 diabetes

Identifiers

PMID31438915
PMCPMC6704621
OpenAlexW2969694511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.